Literature DB >> 23143633

Simultaneous determination of the combined drugs of ceftriaxone sodium, metronidazole, and levofloxacin in human urine by high-performance liquid chromatography.

Hanwen Sun1, Hongliu Wang, Xusheng Ge.   

Abstract

AIM: To develop a new high-performance liquid chromatography (HPLC) method for simultaneous determination of the combined drugs (ceftriaxone sodium, metronidazole, and levofloxacin) in human urine.
METHODS: Ceftriaxone sodium, metronidazole, and levofloxacin were separated on a Kromasil 100-5 C18 (250 mm × 4.6 mm, 5 μm, AKZO NOBEL, Bohus, Sweden) analytical column, using the mobile phase consisted of 1.5 mM KH(2) PO(4) (pH 4.5) with 0.0125% triethylamine-methnol (70:30, v/v). Ceftriaxone sodium, metronidazole, and levofloxacin were detected by a photodiode-array detector at 247, 320, 292 nm, respectively.
RESULTS: Under optimal conditions, the effective separation of ceftriaxone sodium, metronidazole, and levofloxacin was achieved. A good linearity with the correlation coefficients more than 0.999 was demonstrated. The detection limits of ceftriaxone sodium, metronidazole, and levofloxacin were 0.05, 0.01, and 0.25 μg/ml, respectively, and the average recoveries in human urine were in the range from 97.73 to 100.7% with the average relative standard deviation (RSD) in the range of 2.5% and 3.0%.
CONCLUSION: The proposed method was sensitive, accurate, and rapid. This work may provide a reference for clinical rational drug use and methodology for the pharmacokinetics study of the combined drugs.
© 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23143633      PMCID: PMC6807611          DOI: 10.1002/jcla.21551

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  19 in total

1.  An HPLC assay and a microbiological assay to determine levofloxacin in soft tissue, bone, bile and serum.

Authors:  S Böttcher; H von Baum; T Hoppe-Tichy; C Benz; H G Sonntag
Journal:  J Pharm Biomed Anal       Date:  2001-05       Impact factor: 3.935

2.  Determination of levofloxacin in plasma, bronchoalveolar lavage and bone tissues by high-performance liquid chromatography with ultraviolet detection using a fully automated extraction method.

Authors:  S Djabarouti; E Boselli; B Allaouchiche; B Ba; A T Nguyen; J B Gordien; J M Bernadou; M C Saux; D Breilh
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2004-01-05       Impact factor: 3.205

3.  Simultaneous measurement of pazufloxacin, ciprofloxacin, and levofloxacin in human serum by high-performance liquid chromatography with fluorescence detection.

Authors:  Satoshi Watabe; Yoshiaki Yokoyama; Kazuyuki Nakazawa; Kimikazu Shinozaki; Rika Hiraoka; Kei Takeshita; Yukio Suzuki
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2010-05-01       Impact factor: 3.205

4.  Simple and sensitive method for determination of metronidazole in human serum by high-performance liquid chromatography.

Authors:  M J Galmier; A M Frasey; M Bastide; E Beyssac; J Petit; J M Aiache; C Lartigue-Mattei
Journal:  J Chromatogr B Biomed Sci Appl       Date:  1998-12-11

5.  Biowaiver monographs for immediate release solid oral dosage forms: levofloxacin.

Authors:  Marcelle O Koeppe; Rodrigo Cristofoletti; Eduardo F Fernandes; Silvia Storpirtis; Hans E Junginger; Sabine Kopp; Kamal K Midha; Vinod P Shah; Salomon Stavchansky; Jennifer B Dressman; Dirk M Barends
Journal:  J Pharm Sci       Date:  2011-01-21       Impact factor: 3.534

6.  Analysis of 12 beta-lactam antibiotics in human plasma by HPLC with ultraviolet detection.

Authors:  Brett C McWhinney; Steven C Wallis; Tara Hillister; Jason A Roberts; Jeffrey Lipman; Jacobus P J Ungerer
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2010-05-24       Impact factor: 3.205

7.  Moxifloxacin is non-inferior to combination therapy with ceftriaxone plus metronidazole in patients with community-origin complicated intra-abdominal infections.

Authors:  Joseph Solomkin; Yu-Pei Zhao; En-Ling Ma; Min-Jun Chen; Barbara Hampel
Journal:  Int J Antimicrob Agents       Date:  2009-08-18       Impact factor: 5.283

8.  Simultaneous multiresidue determination of metronidazole and spiramycin in fish muscle using high performance liquid chromatography with UV detection.

Authors:  Hadir M Maher; Rasha M Youssef; Riad H Khalil; Sabry M El-Bahr
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2008-11-01       Impact factor: 3.205

9.  Prediction of incompatibility of ceftriaxone sodium with calcium ions using the ionic product.

Authors:  Yuka Nakai; Emi Tokuyama; Miyako Yoshida; Takahiro Uchida
Journal:  Yakugaku Zasshi       Date:  2010-01       Impact factor: 0.302

10.  Ion pair high-performance liquid chromatographic assay for ceftriaxone.

Authors:  G G Granich; D J Krogstad
Journal:  Antimicrob Agents Chemother       Date:  1987-03       Impact factor: 5.191

View more
  2 in total

1.  Novel fluorescent membrane for metronidazole sensing prepared by covalent immobilization of a pyrenebutyric acid derivative.

Authors:  Asigul Muhammad; Turghun Muhammad; Osmanjan Yimit; Burabiye Yakup
Journal:  J Fluoresc       Date:  2013-03-08       Impact factor: 2.217

2.  Liquid chromatography-tandem mass spectrometry for the simultaneous quantitation of ceftriaxone, metronidazole and hydroxymetronidazole in plasma from seriously ill, severely malnourished children.

Authors:  Martin Ongas; Joseph Standing; Bernhards Ogutu; Joseph Waichungo; James A Berkley; Karin Kipper
Journal:  Wellcome Open Res       Date:  2017-06-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.